about
AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation.The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivityDownstream signaling pathways in mouse adipose tissues following acute in vivo administration of fibroblast growth factor 21A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscleAMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamusPotentiation of insulin-mediated glucose lowering without elevated hypoglycemia risk by a small molecule insulin receptor modulatorThe PP2A-associated protein alpha4 is an essential inhibitor of apoptosisInsulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta)Novel aspects of the regulation of glycogen storage.The glucagon receptor is involved in mediating the body weight-lowering effects of oxyntomodulin.Exercise induces isoform-specific increase in 5'AMP-activated protein kinase activity in human skeletal muscle.Structure and chromosomal localization of the human glycogenin-2 gene GYG2.Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states.Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B.AMP kinase is not required for the GLUT4 response to exercise and denervation in skeletal muscle.Bone loss in the oestrogen-depleted rat is not exacerbated by sitagliptin, either alone or in combination with a thiazolidinedione.Engineering Glucose Responsiveness Into Insulin.A glucose-responsive insulin therapy protects animals against hypoglycemia.Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes.Initiation of glycogen synthesis in yeast. Requirement of multiple tyrosine residues for function of the self-glucosylating Glg proteins in vivoSelf-glucosylation of glycogenin, the initiator of glycogen biosynthesis, involves an inter-subunit reactionGlucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemiaChronic treatment with a glucagon receptor antagonist lowers glucose and moderately raises circulating glucagon and glucagon-like peptide 1 without severe alpha cell hypertrophy in diet-induced obese mice
P50
Q24541475-E667B190-8487-41E6-B72B-9DBFBD8D8F26Q24554361-3C9C2232-7110-4D37-AF84-FDCD9DF5BA82Q27308344-B735574E-AA4D-40F6-8FD0-2C9392109489Q28199222-552C7848-F19A-4161-B6DC-D7AC55430488Q28254114-E545E299-8314-4BA5-AA7A-3F6EFB948C5DQ28544827-72034537-5D4E-41F6-B221-451CDCC9B750Q28589531-89CB177E-BF50-406A-974E-AE0C1DD3590FQ29615537-27DB7064-5ACB-4B6B-A898-5BBA65969B96Q33599400-1E99D644-D109-4B55-96BE-2E96DDB965BAQ42255930-AFCF41CC-6464-4096-B687-C25CBEFCA7A2Q42490447-99636DCE-7E08-4A09-B9A0-53D571DDD0FAQ42621794-35587D18-7258-4EF2-9FE2-9EDD015C9027Q42813296-5B9EA8B5-9FB5-40BB-A663-A4118E0729CCQ44605205-CEF1026A-6C79-49BB-8548-76024E93F821Q44912753-78CD72C9-AA0B-482C-9EE8-4FBB11DFA6A8Q45913829-E2472B4B-D54C-46F8-ACA4-DEC8740CECF4Q47386379-177EDF3B-18D5-4BF2-90ED-E8E6F39F62E5Q50101787-25A70BDC-9E9A-4529-89D9-391D8B835002Q51497444-A838562A-56DD-4878-BC06-DD8EF016B008Q71742601-C4259820-A10D-476D-AD09-F03CDE150E87Q74525055-F9296951-1D3B-4292-9A36-2D6DCE6C786FQ79387626-4A7BC8BA-2CCE-4E39-9D3A-8D19D5E5E7D5Q84417668-D8D6C705-1AF6-4D6E-B1DC-3E5772C9804D
P50
description
researcher ORCID ID = 0000-0001-8081-2401
@en
wetenschapper
@nl
name
James Mu
@ast
James Mu
@en
James Mu
@es
James Mu
@nl
type
label
James Mu
@ast
James Mu
@en
James Mu
@es
James Mu
@nl
prefLabel
James Mu
@ast
James Mu
@en
James Mu
@es
James Mu
@nl
P1153
7102233138
P31
P496
0000-0001-8081-2401